Synthesis and anticonvulsant evaluation of a series of N-Cbz-α-aminoglutarimides

Archives of Pharmacal Research

Volumn 19, Issue 3, 1996, Pages 248-250

  Lee, Jaewon ^a   Choi, Jongwon ^b   Park, Minsoo ^b  

^a Koshin Medical Center Pusan   (South Korea)

^b Kyungsung University   (South Korea)

Author keywords

Anticonvulsant; Glutarimide; Maximal electric shock(MES); Pentylenetetrazole induced seizure(PTZ)

Indexed keywords

EID: 19044395156     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976901     Document Type: Article

References (15)

1. Andersen, K. E., Braestrup, C. B., Gronvald, F. C., Jorgensen, A. S., Nielsen, E. B., Sonnewald, U., Sorensen, P. O., Suzdak, P. D. and Knutsen, L. J. S., The Synthesis of Novel GABA Uptake Inhibitors. 1. Elucidation of the Structure-Activity Studies Leading to the Choice of (R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (Tiagabine) as an Anticonvulsant Drug Candidate, J. Med. Chem., 36, 1716-1725 (1993).
2. Bornstein, M. R. and Doukas, P. H., Anticonvulsant Activity of Indanylspirosuccinimide Mannich Bases, J. Pharm. Sci., 76, 300-302 (1987).
3. Brouillette, W. J., Jestkov, V. P., Brown, M. L., Akhatar, M. S., DeLrey, T. M. and Brown, G. B., Bicycloc Hydantoins with a Bridgehead Nitrogen, Comparison of Anticonvulsant Activities with Binding to the Neuronal Voltage-Dependent Sodium Channel, J. Med. Chem., 37, 3289-3293 (1994).
4. Harvey, R. A. and Champe, P.C., Lippincott's illustrated Reviews: Pharmacology, J.B. Lippincott company, 1992, Chap.15.
5. Hays, S. J., Rice, M. J., Ortwine, D. F., Johnson, G., Schwarz, R. D., Boyd, D. K., Coperando, L.F., Vartanian, M. G., and Boxer, P. A., Substituted 2-Benzothiazolamines as Sodium Flux Inhibitors: Quantitative Structure-Activity Relationships and Anticonvulsant Activity, J. Pharm. Sci., 83, 1425-1432 (1994) and references cited therein.
6. Heckendorn, R., Allgeier, H., Baud, J., Gundenhauser, W. and Angst, C., Synthesis and Binding Properties of 2-Amino-5-phosphono-3-pentenoic acid Photoaffinty Ligands as Probes for the Glutamate Recognition Site of the NMDA Receptor. J. Med. Chem., 36, 3721-3726 (1993).
7. Itoh, M., Peptide. 1. Selective protection of a- or Side chain Carboxyl Groups of Aspartic and Glutamic Acid. A Facile Synthesis of β-Aspartyl and γ-Glutamyl Peptides. Chem. Pharm. Bull., 17, 1679-1686 (1969).
8. Kohn, H., Sawhney, K. N., Robertson, D. W. and Leander, J. D., Anticonvulsant Properties of N-substituted α,α-Diamino acid Derivatives. J. Pharm. Sci., 83, 689-691 (1994).
9. Kohn, H., Sawhney, K. N., Bardel, P., Robertson, D. W. and Leander, J. D., Synthesis and Anticonvulsant Activities of α-Heterocyclic α-Acetamido-N-benzylacetamide Derivatives. J. Med. Chem., 36, 3350-3360 (1993).
10. Kornet, M. J. Synthesis and Anticonvulsant Evaluation of N-Aminosuccinimides. J. Pharm. Sci., 73, 405-406 (1984).
11. N'Goka, V., Schlewer, G., Linget, J. M., Chambon, J. P. and Wermuth, C. G., GABA uptake Inhibitors: Construction of a General Pharmacophore Model and Successful Prediction of a New Representative., J. Med. Chem., 34, 2547-2557 (1991).
12. Sandler, S. R. and Karo, W., Organic Functional Group Preparation, Vol. III, Academic Press, N. Y., 1972, p. 253.
13. Sun, Z. Y., Kwon, C. H. and Wurpel, N. D., Srtucture-Activity Study of 5-Substituted 1-Carbobenzoxy-2-iminohydantoins as Potential Anticonvulsant Agents. J. Med. Chem., 37, 2841-2845 (1994) and references cited therein.
14. Swinyard, E. A., Woodhead, J. H., White, H. S. and Frankline, M. R., General Principles, Experimental Section, Quantification and Evaluation of Anticonvulsants in Antiepileptic Drugs, 3rd Ed: In Levy, R., et al (Eds.), Ravan Press, N. Y., 1989, p. 88.
15. Wilder, B. J., Seizure disorder-A Pharmcological Approach to Treatment, Ravan Press, N.Y., 1985, pp. 23-27.